Compounds > daunorubicin
Page last updated: 2024-08-23

daunorubicin and acetyl-aspartyl-glutamyl-valyl-aspartal

daunorubicin has been researched along with acetyl-aspartyl-glutamyl-valyl-aspartal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Kwon, KB; Park, BH; Park, EK; Ryu, DG1

Other Studies

2 other study(ies) available for daunorubicin and acetyl-aspartyl-glutamyl-valyl-aspartal

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
D4-GDI is cleaved by caspase-3 during daunorubicin-induced apoptosis in HL-60 cells.
    Experimental & molecular medicine, 2002, Mar-31, Volume: 34, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Caspase Inhibitors; Caspases; Cysteine Proteinase Inhibitors; Daunorubicin; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Activation; Guanine Nucleotide Dissociation Inhibitors; HL-60 Cells; Humans; Oligopeptides; rho GTP-Binding Proteins; rho Guanine Nucleotide Dissociation Inhibitor beta; rho-Specific Guanine Nucleotide Dissociation Inhibitors

2002